Achievement of deep molecular response and treatment-free remission with asciminib treatment in CML Ryo YoshimaruYosuke Minami Case Report 18 July 2024
Characteristic and recurrent pathophysiological features of non-duodenal follicular lymphoma of the small intestine Yosuke MatsumotoTetsuya MasudaMasafumi Taniwaki Letter to the Editor 17 July 2024
Survival impact of response within the first year in a multicenter prospective observational study of chronic GVHD in a Japanese cohort Chikako OhwadaEmiko SakaidaYoshinobu Kanda Original Article 17 July 2024
Dynamic changes in femoral bone marrow MRI in patients with chronic myelogenous leukemia Shohei IkedaManabu SuzukiMasatsugu Ohta Images in Hematology 15 July 2024
Trametinib for a child with refractory Rosai–Dorfman–Destombes disease harboring a novel somatic mutation in MAP2K1 Yuichi TaneyamaAkira MorimotoSana Yokoi Case Report 14 July 2024
Lenalidomide and pomalidomide modulate hematopoietic cell expansion and differentiation in the presence of MSC Sumie FujiiYasuo Miura Original Article Open access 12 July 2024
Immunohistochemical differentiation of extramedullary acute myeloid leukemia from blastic plasmacytoid dendritic cell neoplasm Shuhei KurosawaTomonori Nakazato Images in Hematology 10 July 2024
Heparin-induced thrombocytopenia with very high antibody titer is associated with slower platelet recovery and higher risk of thrombosis Akash MukherjeeCesar GentilleLawrence Rice Original Article 08 July 2024
High-dose cytarabine plus gemtuzumab ozogamicin as consolidation therapy in patients with favorable- or intermediate-risk acute myeloid leukemia Shuki OyaHidetoshi OzawaKoji Nagafuji Original Article 04 July 2024
CAR-T cell therapy in AML: recent progress and future perspectives Shoji SaitoYozo Nakazawa Progress in Hematology 04 July 2024
Comprehensive analysis of microRNAs modulated by histone deacetylase inhibitors identifies microRNA-7-5p with anti-myeloma effect Masahiro YamadaSho IkedaNaoto Takahashi Original Article 02 July 2024
Efficacy and safety outcomes in Japanese patients with low-risk polycythemia vera treated with ropeginterferon alfa-2b Kazuya ShimodaAlbert QinKeita Kirito Rapid Communication Open access 01 July 2024
Allogeneic stem cell transplantation for inherited metabolic disorders: 35 years’ experience at a single institution Hiromasa YabeTakashi KoikeMiharu Yabe Original Article 01 July 2024
Detection of factor XIII inhibitors in 33 patients with autoimmune factor XIII deficiency in Japan Masayoshi SouriTsukasa OsakiAkitada Ichinose Original Article 19 June 2024
Asciminib in Patients With CML-CP Previously Treated With ≥ 2 Tyrosine Kinase Inhibitors: 96-Week Results From the Japanese Subgroup Analysis of the ASCEMBL Study Yosuke MinamiNoriko DokiItaru Matsumura Original Article Open access 18 June 2024
Novel treatment strategies for hematological malignancies in the immunotherapy era Yoichi Imai Progress in Hematology 11 June 2024 Pages: 3 - 5
Myeloid sarcoma with plasmacytoid dendritic cell-like proliferation associated with IKZF1, ETV6 and DNMT3A mutations Kengo SuzukiDaisuke KoyamaTakayuki Ikezoe Case Report 11 June 2024
CRISPR/Cas9 gene editing clarifies the role of CD33 SNP rs12459419 in gemtuzumab ozogamicin-mediated cytotoxicity Shuki OyaHidetoshi OzawaKoji Nagafuji Original Article 10 June 2024
Cellular and humoral immunogenicity against SARS-CoV-2 vaccination or infection is associated with the memory phenotype of T- and B-lymphocytes in adult allogeneic hematopoietic cell transplant recipients Takaaki KonumaMegumi Hamatani-AsakuraYasuhito Nannya Original Article Open access 06 June 2024
GPS2 promotes erythroid differentiation in K562 erythroleukemia cells primarily via NCOR1 Ying LuWen-Bing MaRong-Hua Yin Original Article 30 May 2024
Isatuximab with pomalidomide-dexamethasone in relapsed/refractory multiple myeloma: post-marketing surveillance in Japan Nami TagamiMichihiro UchiyamaShinsuke Iida Original Article Open access 29 May 2024
New classifications of B-cell neoplasms: a comparison of 5th WHO and International Consensus classifications Kennosuke KarubeAkira SatouSeiichi Kato Progress in Hematology 28 May 2024
Clinical management of iron deficiency anemia in Japan: iron prescription patterns, treatment effectiveness, and assessments Miyako KosugiRyo TakezawaKatsuya Ikuta Original Article Open access 28 May 2024
Long-range and real-time PCR identification of a large SERPINC1 deletion in a patient with antithrombin deficiency Shinya MatsumotoTakeshi UchiumiDongchon Kang Original Article 27 May 2024
Chemotherapy-induced aseptic thrombophlebitis with an air bubble in the thrombus Osamu ImatakiHaruyuki FujitaMakiko Uemura Images in Hematology 26 May 2024 Pages: 1 - 2
B-cell prolymphocytic leukemia: an enduring bona fide entity Miguel S. Gonzalez-ManceraJean LopateguiSerhan Alkan Case Report 26 May 2024
Ruxolitinib in steroid-refractory acute graft-vs-host disease: Japanese subgroup analysis of the randomized REACH2 trial Takanori TeshimaYasushi OnishiMakoto Onizuka Original Article Open access 25 May 2024 Pages: 106 - 116
Novel CAR T cell therapies for patients with large B cell lymphoma Hideki GotoMasahiro OnozawaTakanori Teshima Progress in Hematology 25 May 2024 Pages: 6 - 14
WT1-guided pre-emptive therapy after allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia Shota AraiTakayoshi TachibanaHideaki Nakajima Original Article 25 May 2024
Current progress of CAR-T-cell therapy for patients with multiple myeloma Takahiro NakashimaYuki Kagoya Progress in Hematology 23 May 2024 Pages: 15 - 22
A review of the Augustine blood group system Jing ZhongChunping MoLingbo Li Review Article 20 May 2024 Pages: 44 - 49
Retrospectively diagnosed autoimmune VWF deficiency in a patient with repeated hemorrhagic events after two common colds Yoshiyuki OgawaAkitada IchinoseHiroshi Handa Case Report 18 May 2024
Reply to the Dr. Murphy’s comment Hirokazu Kashiwagi Letter to the Editor 16 May 2024 Pages: 147 - 147
Outcome of 3q26.2/MECOM rearrangements in chronic myeloid leukemia Hiroki AkiyamaHagop KantarjianKoji Sasaki Original Article 15 May 2024
Metabolic dependencies of acute myeloid leukemia stem cells Xiangguo ShiMengdie FengDaisuke Nakada Progress in Hematology 15 May 2024
Serum monoclonal immunoglobulin light-chain detection differs between immunofixation electrophoresis methods in patients with AL amyloidosis Yawara KawanoNao NishimuraJun-Ichirou Yasunaga Original Article 13 May 2024
A case of acute lung injury in a peripheral blood stem cell donor mobilized with pegylated recombinant human granulocyte colony-stimulating factor Lin LiuDing-song ZhangSan-bin Wang Case Report 10 May 2024
Understanding the intrinsic biology of diffuse large B-cell lymphoma: recent advances and future prospects Yusuke NaoiDaisuke Ennishi Progress in Hematology 10 May 2024
Modeling and therapeutic targeting of t(8;21) AML with/without TP53 deficiency Wenyu ZhangJingmei LiSusumu Goyama Original Article Open access 03 May 2024
Highly sensitive detection of Epstein-Barr virus-infected cells by EBER flow FISH Dan TomomasaKay TanitaHirokazu Kanegane Original Article 03 May 2024
Evolution of natural killer cell-targeted therapy for acute myeloid leukemia Yuta KaitoYoichi Imai Progress in Hematology 01 May 2024 Pages: 34 - 43
Protection from bleeds during physical activity in people with haemophilia: the role of factor levels: a response to Nogami et al. (2023) Olav VerslootJ. van der NetK. Fischer Letter to the Editor 01 May 2024
Clinical features of immature leukemias in children Daichi SajikiNao YoshidaAsahito Hama Original Article 30 April 2024 Pages: 117 - 127
Post-transfusion purpura and adult primary thrombocytopenia Philip Murphy Letter to the Editor 29 April 2024 Pages: 146 - 146
Acute mixed-lineage leukemia treated with desensitization therapy prior to HLA–haploidentical transplantation with high donor-specific antibodies Kengo KatsukiTakayoshi TachibanaHideaki Nakajima Case Report 27 April 2024
Mendelian randomization reveals association of gut microbiota with Henoch–Schönlein purpura and immune thrombocytopenia Chendong JiangShu DengEnwu Yuan Original Article Open access 26 April 2024 Pages: 50 - 59
CEBPA mutations in acute myeloid leukemia: implications in risk stratification and treatment Feng-Ming TienHsin-An Hou Progress in Hematology 26 April 2024
Cytomegalovirus infection during daratumumab therapy in patients with newly diagnosed multiple myeloma Taku KikuchiNobuhiro TsukadaTadao Ishida Original Article 19 April 2024 Pages: 91 - 95